Skip Navigation
Skip to contents

J Korean Med Sci.  2023 May;38(17):e135. 10.3346/jkms.2023.38.e135.

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone

Affiliations
  • 1Department of Polymer Science and Engineering, Chungnam National University, Daejeon, Korea
  • 2Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Korea
  • 3Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, Korea
  • 4Brain Research Institute, College of Medicine, Chungnam National University, Daejeon, Korea

Abstract

Background
In this study, we prepared and evaluated an injectable poloxamer (P407) hydrogel formulation for intratympanic (IT) delivery of dexamethasone (DEX).
Methods
DEX-loaded P407 hydrogels were characterized in terms of thermogelation, drug loading capacities, particle size, and drug release. The in vivo toxicity and drug absorption of the DEX-loaded P407 formulation after IT injection were evaluated using an animal model by performing histopathological analysis and drug concentration measurements.
Results
The P407 hydrogel effectively solubilized hydrophobic DEX and demonstrated a sustained release compared to the hydrophilic DEX formulation. The in vivo study showed that the hydrogel formulation delivered considerable drug concentrations to the inner ear and displayed a favorable safety profile without apparent cytotoxicity or inflammation.
Conclusion
P407 hydrogel can be useful as an injectable inner ear delivery formulation for hydrophobic drugs due to their biocompatibility, drug-solubilizing capacity, thermogelation, and controlled release.

Keyword

Poloxamer; Dexamethasone; Injectable Hydrogel; Intratympanic Injection; Inner Ear Delivery
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr